Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SciSparc Ltd. - Ordinary Shares (NQ: SPRC ) 0.6730 +0.0300 (+4.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 4,002,781 Open 0.6700 Bid (Size) 0.6500 (88) Ask (Size) 0.6650 (5) Prev. Close 0.6430 Today's Range 0.5952 - 0.7001 52wk Range 0.5952 - 15.86 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer July 22, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million July 17, 2024 From SciSparc Ltd Via GlobeNewswire Performance YTD -86.78% -86.78% 1 Month -24.90% -24.90% 3 Month -44.84% -44.84% 6 Month -80.03% -80.03% 1 Year -95.13% -95.13% More News Read More Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 16, 2024 Via Benzinga SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification July 16, 2024 From SciSparc Ltd Via GlobeNewswire Mizuho Just Issued a Warning on Palantir (PLTR) Stock July 16, 2024 Via InvestorPlace Why Is SciSparc (SPRC) Stock Up 25% Today? July 16, 2024 Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 16, 2024 Via InvestorPlace SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss July 16, 2024 From SciSparc Ltd Via GlobeNewswire Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket July 11, 2024 Via Benzinga SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company July 08, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Secures Strategic Advantage with Grant of European Patent May 31, 2024 From SciSparc Ltd Via GlobeNewswire Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Via Benzinga Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket April 16, 2024 Via Benzinga Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Via Benzinga SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification April 11, 2024 Via Benzinga SciSparc to Acquire AutoMax April 11, 2024 From SciSparc Ltd Via GlobeNewswire Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket April 11, 2024 Via Benzinga SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression March 27, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research March 21, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Granted Another Patent, Strengthening its Core Technology in Canada March 18, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial March 14, 2024 From SciSparc Ltd Via GlobeNewswire Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors March 12, 2024 Via Benzinga SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure March 12, 2024 From SciSparc Ltd Via GlobeNewswire Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments March 08, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder March 08, 2024 From SciSparc Ltd Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.